Ciclosporin eye drops launched for keratitis

The recommended dose of Ikervis is one drop applied to the affected eye(s) once daily at bedtime.
The recommended dose of Ikervis is one drop applied to the affected eye(s) once daily at bedtime.

Further information
View Ikervis drug record
Summary of Product Characteristics
Manufacturer: Santen

Ikervis (ciclosporin) is indicated for the treatment of severe keratitis in adults with dry eye disease that has not improved despite treatment with tear substitutes.

As an immunosuppressant, ciclosporin acts to improve ocular surface damage and reduce inflammation.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New antibiotic prescribing guidance issued for pneumonia

New antibiotic prescribing guidance issued for pneumonia

NICE has published antimicrobial prescribing guidelines...

MIMS summary of NICE COPD guidance updated

MIMS summary of NICE COPD guidance updated

Prescribers can now consult the quick-reference MIMS...

Soft-mist inhaler now available as reusable device

Soft-mist inhaler now available as reusable device

Respimat is now available as a reusable inhaler that...

NICE recommends 'innovative' treatment for type I diabetes

NICE recommends 'innovative' treatment for type I diabetes

Dapagliflozin (Forxiga) has been approved for routine...